³¤´º¹¤Òµ´óѧÄÉÃ×»¯Ñ§ÉúÎïѧ×é½ÓÊÕ»¯Ñ§ºÍÉúÎÑÐÉú£º
µ¼Ê¦»ù±¾ÐÅÏ¢
ÀîÞÉ£¬1979Äê³öÉú£¬½ÌÊÚ£¬²©Ê¿Éúµ¼Ê¦¡£2007Ä격ʿ±ÏÒµÓÚÖйú¿ÆѧԺ³¤´ºÓ¦Óû¯Ñ§Ñо¿Ëù£¬2007ÄêÖÁ2014ÄêÔÚÃÀ¹úÖªÃû¿ÆÑÐ/½ÌÓý»ú¹¹´Óʲ©Ê¿ºó¿ÆÑй¤×÷7Ä꣬2014Äê×÷Ϊº£Íâ¸ß²ã´ÎÈ˲ű»³¤´º¹¤Òµ´óѧƸΪ½ÌÊÚÈ«Ö°Òý½ø¡£"Öйú¿ÆѧԺԺ³¤½±Ìرð½±(Top 20)¡±£¬¡°Öйú¿ÆѧԺÓÅÐ㲩ʿÂÛÎĽ±(Top 50)¡±£¬¡°½ÌÓý²¿È«¹ú°ÙƪÓÅÐ㲩ʿÂÛÎÄÌáÃû½±¡±£¬¡°¼ªÁÖÊ¡¿Æ¼¼½ø²½Ò»µÈ½±¡± "¼ªÁÖÊ¡È˲ſª·¢»ù½ð"»ñµÃÕß¡£Æù½ñÒÑÒÔµÚÒ»×÷Õß»òͨѶ×÷ÕßÉí·ÝÔÚ¹ú¼Ê¶¥¼âÆÚ¿¯£¬ÈçÃÀ¹ú¿ÆѧԺԺ¿¯£¨Proc. Natl. Acad. Sci. USA£¬ IF: 9.809£©£¬ºËËáÑо¿£¨Nucleic Acids Research£¬IF: 11.147£©£¬ÄÉÃ×ͨѶ£¨Nano Lett. IF:12.297£©£¬ÉúÎï²ÄÁÏ£¨Biomaterials£¬IF:10.273£©£¬Small£¨Small£¬IF:10.856£©ACSÓ¦ÓòÄÁÏÓë½çÃ棨ACS Applied Materials & Interfaces£¬IF:8.456£©·¢±íSCIË÷ÒýÂÛÎÄ22ƪ£¬ÆäÖÐ1ÇøÂÛÎĵÄ18ƪ£¬ESI¸ß±»ÒýÂÛÎÄ1ƪ, ¹²±»35¸ö¹ú¼Ò³¬¹ý100¼ÒÑо¿»ú¹¹ÒýÓÃ700Óà´Î£¬ÆäÖе¥ÆªÒýÓÃÂʸߴï180´Î£»ÏµÁÐÐÔ¿ÆÑй¤×÷µÃµ½Á˹úÄÚÍâÖªÃû¿ÆѧýÌ壬Èç¿Æѧʱ±¨£¬Ó¢¹úÎïÀíѧ»áÍøÕ¾Nanotechweb.org£¬ÃÀ¹ú¿ÆѧýÌåNaturalnews, Cancer Weekly, ÃÀ¹úÕþ¸®ÍøÕ¾Nano.cancer.govµÄÁÁµã±¨µÀ£¬²¢µÃµ½Á˹㷺µÄתÔØ¡£Ö÷³Ö¹ú¼Ò×ÔÈ»¿Æѧ»ù½ð£¬¼ªÁÖÊ¡½ÌÓýÌü¡¢¿Æ¼¼Ìü¡¢ÈËÉçÌüµÈ¿ÆÑÐÏîÄ¿¡£
Ö÷ÒªÑо¿·½ÏòΪ£º°ÐÏòÐÔÄÉÃ×ÉúÎï²ÄÁÏÔÚ¼²²¡ÕïÁÆÖеÄÓ¦ÓÃ
¸öÈË¿ÆÑгɹûWeb of Sciences PublonsÍøÕ¾ÐÅÏ¢£ºhttps://publons.com/researcher/2495793/xi-li/
ÁªÏµ·½Ê½£ºqq: 2575799707
µç×ÓÓÊÏ䣺lixi-cn@hotmail.com
½±ÀøÓëÈÙÓþ
•2015 ¼ªÁÖÊ¡È˲ſª·¢»ù½ð
•2010 ¼ªÁÖÊ¡¿Æ¼¼½ø²½Ò»µÈ½±
•2010 ½ÌÓý²¿È«¹úÓÅÐ㲩ʿѧλÂÛÎÄÌáÃû½±
•2009 Öйú¿ÆѧԺÓÅÐ㲩ʿÂÛÎÄ
•2007 Öйú¿ÆѧԺԺ³¤Ìرð½±
´ú±íÐÔÂÛÎÄ
1. Li Wang, Xi Li*, et al., Nitric Oxide Stimulated Programmable Drug Release of Nanosystem for Multidrug Resistance Cancer Therapy, Nano Letters, 2019, 19, 6800−6811. (IF:12.297)
2. Xiaomin Ma, Xi Li*, et al., Hollow, Rough, and Nitric Oxide-Releasing Cerium Oxide Nanoparticles for Promoting Multiple Stages of Wound Healing. Advanced Healthcare Materials, 2019, 1900256. (IF:6.27)
3. Yanlin Feng, Xi Li*, et al., Time-staggered delivery of erlotinib and doxorubicin by gold nanocages with two smart polymers for reprogrammable release and synergistic with photothermal therapy, Biomaterials, 2019, 127, 119327. (IF:10.273)
4. Yanlin Feng, Xi Li*, et al., Differential photothermal and photodynamic performance behaviors of gold nanorods, nanoshells and nanocages under identical energy conditions, Biomaterials Science, 2019, 7(4), 1448-1462. (IF:5.251)
5. Yun Chang, Xi Li*, et al., Resonance Energy Transfer-Promoted Photothermal and Photodynamic Performance of Gold- Copper Sulfide Yolk-Shell Nanoparticles for Chemophototherapy of Cancer, Nano Letters, 2018, 18(2), 886-897. (IF:12.297, ESI¸ß±»ÒýÂÛÎÄ)
6. Yan Cheng, Xi Li*, et al., Simulated Sunlight-Mediated Photodynamic Therapy for Melanoma Skin Cancer by Titanium-Dioxide-Nanoparticle-Gold-Nanocluster-Graphene Heterogeneous Nanocomposites, Small, 2017, 13(20), 1603935. (IF:10.856)
7. Ning Liu, Xi Li*, et al., {101}-{001} Surface Heterojunction-Enhanced Antibacterial Activity of Titanium Dioxide Nanocrystals Under Sunlight Irradiation, ACS Applied Materials & Interfaces, 2017, 9(7), 5907-5915. (IF:8.456)
8. Yanlin Feng, Xi Li*, et al., Understanding the Property-Activity Relationships of Polyhedral Cuprous Oxide Nanocrystals in Terms of Reactive Crystallographic Facets, Toxicological Sciences, 2017, 15(6), 480-491. (IF:3.564)
9. Yun Chang, Xi Li*, et al., Crystallographic facet-dependent stress responses by polyhedral lead sulfide nanocrystals and the potential "safe-by-design" approach, Nano Research, 2016, 9(12), 3812-3827. (IF:8.515)
10. Xi Li, Bing Yan*, et al., Enhancement of Cell Recognition in vitro by Dual-Ligand Cancer Targeting Gold Nanoparticles, Biomaterials, 2011, 32(10), 2540-2545. (IF:10.273)
11. Xi Li, Xiaogang Qu*, et al., Carboxyl-Modified Single-Walled Carbon Nanotubes Selectively Induce Human Telomeric I-motif Formation, Proc. Natl. Acad. Sci. USA, 2006, 103, 19658-19663. (Direct submission, IF: 9.809, 2006¹ú¼Ê»ùÒòÖÎÁÆ°ÙƪÂÛÎÄ)
12. Xi Li, Xiaogang Qu*, et al., Carbon Nanotubes Selective Destabilization of Duplex and Triplex DNA and Inducing B-A Transition in Solution, Nucleic Acids Research, 2006, 34, 3670-3676. (IF: 11.147)
¶ÁÑÐÆÚ¼ä´ýÓö£º
1£©³¤´º¹¤Òµ´óѧУ¼¶£ºÃ¿¸öÔ¿ɻñµÃ600ÔªµÄ¹ú¼Ò²¹Öú£¬±íÏÖÓÅÐãµÄÑо¿Éú¿É²ÎÆÀ¹ú¼Ò½±Ñ§½ð£¨2ÍòÔª£©¡£Ñ§Ð£¶Ô˶ʿÑо¿ÉúÉèÁ¢ÁËѧҵ½±Ñ§½ð·ÖΪÈý¸öµÈ¼¶£ºÒ»µÈ½±Ñ§½ð£ºÃ¿ÉúÿÄê10000Ôª£¬Õ¼ÆÀ½±Ä꼶˶ʿÑо¿Éú×ÜÈËÊýµÄ10%£»¶þµÈ½±Ñ§½ð£ºÃ¿ÉúÿÄê6000Ôª£¬Õ¼ÆÀ½±Ä꼶˶ʿÑо¿Éú×ÜÈËÊýµÄ20%£»ÈýµÈ½±Ñ§½ð£ºÃ¿ÉúÿÄê3000Ôª£¬Õ¼ÆÀ½±Ä꼶˶ʿÑо¿Éú×ÜÈËÊýµÄ40%(½±Ñ§½ð×ܱÈÀý70%£©¡£
2£©µ¼Ê¦ËùÔÚ²ÄÁϸߵÈÑо¿Ôº½±Ñ§½ð´ýÓö£º6000Ôª/ÈË/Ä꣨½±Ñ§½ð×ܱÈÀý40%£©,
3£©¿ÎÌâ×é´ýÓö£ºË¶Ê¿ÉúÿÔÂÌṩ300‒800ÔªµÄ¿ÆÑв¹Öú£¬²¢²ÎÓë×éÄÚ¿ÆÑгɹûÔñÓŽ±Àø1000-10000¡£
4£©¸ù¾ÝѧϰÒÔ¼°¿ÆÑÐÄÜÁ¦ÔñÓÅÓëÖпÆÔº³¤´ºÓ¦»¯Ëù¡¢ÖйúÅ©¿ÆÔº³¤´ºÌزúËù»òÆäËû¹úÄÚÖªÃûÔºËùÁªºÏÅàÑø£¬ÏíÊܸõ¥Î»Ñ§ÉúͬµÈ´ýÓö£¨²¢Í¬Ê±ÏíÊܳ¤´º¹¤Òµ´óѧÏà¹Ø´ýÓö£©
±¾·½ÏòΪ»¯Ñ§¡¢ÉúÎï½»²æÇ°ÑØѧ¿Æ£¬»¶Ó¹ã´óÓÐÐËȤµÄ»¯Ñ§¡¢ÉúÎÉú±¨¿¼£¨¿É½ÓÊܵ÷¼Á£»¿ÉÔñÓÅÓëÖпÆÔº³¤´ºÓ¦»¯ËùÁªºÏÅàÑø£»±ÏÒµºó¿ÉÍƼöÔÚ¹úÄÚÖªÃûÔºËù»ò³ö¹ú¹¥¶Á²©Ê¿¡¢²©Ê¿ºó£©¡£ |